Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 10(1): 16471, 2020 10 05.
Article in English | MEDLINE | ID: mdl-33020502

ABSTRACT

SARS-CoV-2 has a zoonotic origin and was transmitted to humans via an undetermined intermediate host, leading to infections in humans and other mammals. To enter host cells, the viral spike protein (S-protein) binds to its receptor, ACE2, and is then processed by TMPRSS2. Whilst receptor binding contributes to the viral host range, S-protein:ACE2 complexes from other animals have not been investigated widely. To predict infection risks, we modelled S-protein:ACE2 complexes from 215 vertebrate species, calculated changes in the energy of the complex caused by mutations in each species, relative to human ACE2, and correlated these changes with COVID-19 infection data. We also analysed structural interactions to better understand the key residues contributing to affinity. We predict that mutations are more detrimental in ACE2 than TMPRSS2. Finally, we demonstrate phylogenetically that human SARS-CoV-2 strains have been isolated in animals. Our results suggest that SARS-CoV-2 can infect a broad range of mammals, but few fish, birds or reptiles. Susceptible animals could serve as reservoirs of the virus, necessitating careful ongoing animal management and surveillance.


Subject(s)
Peptidyl-Dipeptidase A/chemistry , Phylogeny , Spike Glycoprotein, Coronavirus/chemistry , Angiotensin-Converting Enzyme 2 , Animals , Betacoronavirus/classification , Betacoronavirus/genetics , Humans , Mammals , Molecular Docking Simulation , Mutation , Peptidyl-Dipeptidase A/classification , Peptidyl-Dipeptidase A/genetics , Peptidyl-Dipeptidase A/metabolism , Protein Binding , SARS-CoV-2 , Spike Glycoprotein, Coronavirus/metabolism
2.
Allergy ; 72(1): 126-136, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27501780

ABSTRACT

BACKGROUND: The mechanisms driving glucocorticoid (GC) insensitivity in patients with severe asthma are still unknown. Recent evidence suggests the existence of GC-insensitive pathways in airway smooth muscle (ASM) caused by a defect in GC receptor (GRα) function. We examined whether other mechanisms could potentially explain the reduced sensitivity of ASM cells to GC in severe asthmatics. METHODS: Airway smooth muscle cells from healthy and severe asthmatic subjects were treated with TNF-α and responses to corticosteroids in both cohorts were compared by ELISA, immunoblot, immunohistochemistry and real-time PCR. Immunohistochemistry and flow cytometry assays were used to assess the expression of the protein phosphatase PP5 in endobronchial biopsies and ASM cells. RESULTS: The production of CCL11 and CCL5 by TNF-α was insensitive to both fluticasone and dexamethasone in ASM cells from severe asthmatic compared to that in healthy subjects. Fluticasone-induced GRα nuclear translocation, phosphorylation at serine 211 and expression of GC-induced leucine zipper (GILZ) were significantly reduced in ASM cells from severe asthmatics compared to responses in healthy subjects. Levels of PP5 were increased in ASM cells from severe asthmatics and PP5 knockdown using siRNA restored fluticasone repressive action on chemokine production and its ability to induce GRα nuclear translocation and GRE-dependent GILZ expression. In vivo PP5 expression was also increased in the ASM bundles in endobronchial biopsies in severe asthmatics. CONCLUSIONS: PP5-dependent impairment of GRα function represents a novel mechanism driving GC insensitivity in ASM in severe asthma.


Subject(s)
Adrenal Cortex Hormones/pharmacology , Anti-Asthmatic Agents/pharmacology , Asthma/immunology , Asthma/metabolism , Drug Tolerance , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/metabolism , Nuclear Proteins/metabolism , Phosphoprotein Phosphatases/metabolism , Adrenal Cortex Hormones/therapeutic use , Adult , Anti-Asthmatic Agents/therapeutic use , Asthma/diagnosis , Asthma/drug therapy , Biomarkers , Cytokines/biosynthesis , Female , Gene Expression Regulation , Humans , Male , Middle Aged , Nuclear Proteins/genetics , Phosphoprotein Phosphatases/genetics , Receptors, Glucocorticoid/metabolism , Respiratory Function Tests , Response Elements , Severity of Illness Index
3.
J Bone Joint Surg Am ; 96(22): e190, 2014 Nov 19.
Article in English | MEDLINE | ID: mdl-25410518

ABSTRACT

BACKGROUND: Despite its limitations, citation analysis remains one of the best currently available tools for quantifying the impact of articles. Bibliometric studies list the "best-sellers" in a single location, and they have been published frequently in many fields during recent years. The purpose of the present study was to report the qualities and characteristics of citation classics in orthopaedic knee research. METHODS: The database of the Institute for Scientific Information (ISI) was utilized for identification of articles published from 1945 to March 2014. All knee articles that had been published in sixty-five orthopaedic and twenty-nine rheumatology journals and that had been cited at least 200 times were identified. The top 100 were selected for further analysis of authorship, source journal, number of citations, citation rate (both since publication and in 2013), geographic origin, article type, and level of evidence. RESULTS: The publication dates of the 100 most-cited articles ranged from 1948 to 2007, with the greatest number of articles published in the 1980s. Citations per article ranged from 2640 to 287. All articles were published in eleven of the ninety-four journals. The leading countries of origin were the U.S. followed by the U.K. and Sweden. The two main focus areas were sports traumatology and degenerative disease. The number of citations per article was also greatest for articles published in the 1980s. Basic research articles were cited more quickly, but not more often, than clinical articles. Most articles represented Level-IV evidence, followed by Levels II, III, and I. CONCLUSIONS: This bibliometric study is likely to include a list of intellectual milestones in orthopaedic knee research. It is apparent that a high level of evidence is not mandatory for an article to gain a large number of citations. Bibliometric reports provide a reflection of the quality of cited research published in a specific field and should therefore provoke thinking within the scientific community.


Subject(s)
Bibliometrics , Orthopedics , Osteoarthritis, Knee/surgery , Humans , Rheumatology , Traumatology
4.
J Dent (Shiraz) ; 14(2): 73-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-24724123

ABSTRACT

STATEMENT OF PROBLEM: Laser irradiation makes structural and chemical changes on the dental hard tissues. These changes alter the level of solubility and permeability of dentin. PURPOSE: The aim of this study was to compare the microhardness and the structural changes in the dentin cavity floor prepared with Er: YAG laser and bur. MATERIAL AND METHODS: In this experimental study, fifteen intact human molars were selected. Two square cavities were prepared on the buccal and lingual surfaces of each tooth. One side was randomly prepared by Er:YAG laser and the other side by bur. The specimens were divided into two halves. Consequently, there were 30 samples in every group. One half was assigned for the Vickers's hardness test and the other one, for determination of Ca and P percentage and atomic elements analysis. The data were analyzed by Paired T-tests through SPSS16 (α≤o.o5). RESULTS: The means and the standard deviation of the microhardness were 69.77±25.62 and 51.33±9.31 Kg/mm(2) in the laser and bur groups, respectively. Statistical analysis showed significant differences between the two groups (p=0.017). Weight percentage of calcium in the laser cavity (65.5) was less than the bur cavities (68.21) and the difference was significant (p= 0.037). CONCLUSION: The hardness of dentin in laser group was higher than the bur group because of the higher mineral content of the dentin. The hardness and the mineral content of dentin are important factors in the bonding effectiveness of the dental materials so with laser cavity preparation, good mineral substrate are available for a better bonding.

5.
Leukemia ; 26(11): 2326-35, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22552008

ABSTRACT

Thalidomide and the immunomodulatory drug, lenalidomide, are therapeutically active in hematological malignancies. The ubiquitously expressed E3 ligase protein cereblon (CRBN) has been identified as the primary teratogenic target of thalidomide. Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes. CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells, as well as lenalidomide- and pomalidomide-induced cytokine production in T cells. Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBN(YW/AA). Overexpression of CRBN wild-type protein, but not CRBN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated reductions in c-myc and IRF4 expression and increases in p21(WAF-1) expression. Long-term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a reduction in CRBN, while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide, CRBN protein was undetectable. Our biophysical, biochemical and gene silencing studies show that CRBN is a proximate, therapeutically important molecular target of lenalidomide and pomalidomide.


Subject(s)
Adjuvants, Immunologic/pharmacology , Antineoplastic Agents/pharmacology , Peptide Hydrolases/drug effects , Thalidomide/analogs & derivatives , Adaptor Proteins, Signal Transducing , HEK293 Cells , Humans , Lenalidomide , Thalidomide/pharmacology , Ubiquitin-Protein Ligases , Ubiquitination
6.
Knee ; 17(6): 421-3, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20061155

ABSTRACT

Congenital knee ankylosis is a rare condition which might be accompanied with other abnormalities or not. To our knowledge, there is no report on true bony ankylosis of the knee. The only ones in the literature include fibrous knee ankylosis. Thus this seems to be the first presentation of true congenital bony fusion of the knee joint.


Subject(s)
Ankylosis/congenital , Knee Joint/abnormalities , Abnormalities, Multiple , Ankylosis/diagnostic imaging , Ankylosis/pathology , Humans , Infant , Knee Joint/diagnostic imaging , Knee Joint/physiopathology , Male , Radiography , Range of Motion, Articular
SELECTION OF CITATIONS
SEARCH DETAIL
...